JP2020512302A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020512302A5 JP2020512302A5 JP2019545923A JP2019545923A JP2020512302A5 JP 2020512302 A5 JP2020512302 A5 JP 2020512302A5 JP 2019545923 A JP2019545923 A JP 2019545923A JP 2019545923 A JP2019545923 A JP 2019545923A JP 2020512302 A5 JP2020512302 A5 JP 2020512302A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- compound according
- alkyl
- group
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CCC(C(C)C)C1C*CC1 Chemical compound CCC(C(C)C)C1C*CC1 0.000 description 2
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022155899A JP7381684B2 (ja) | 2017-03-10 | 2022-09-29 | 遊離可能コンジュゲート |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762469989P | 2017-03-10 | 2017-03-10 | |
| US62/469,989 | 2017-03-10 | ||
| US201762564820P | 2017-09-28 | 2017-09-28 | |
| US62/564,820 | 2017-09-28 | ||
| PCT/IB2018/051579 WO2018163131A1 (en) | 2017-03-10 | 2018-03-10 | Releasable conjugates |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022155899A Division JP7381684B2 (ja) | 2017-03-10 | 2022-09-29 | 遊離可能コンジュゲート |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020512302A JP2020512302A (ja) | 2020-04-23 |
| JP2020512302A5 true JP2020512302A5 (https=) | 2021-04-22 |
| JP7152408B2 JP7152408B2 (ja) | 2022-10-12 |
Family
ID=61764062
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545923A Active JP7152408B2 (ja) | 2017-03-10 | 2018-03-10 | 遊離可能コンジュゲート |
| JP2022155899A Active JP7381684B2 (ja) | 2017-03-10 | 2022-09-29 | 遊離可能コンジュゲート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022155899A Active JP7381684B2 (ja) | 2017-03-10 | 2022-09-29 | 遊離可能コンジュゲート |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11786599B2 (https=) |
| EP (2) | EP3592393B1 (https=) |
| JP (2) | JP7152408B2 (https=) |
| KR (1) | KR20190125310A (https=) |
| CN (1) | CN110545850A (https=) |
| AU (2) | AU2018231832A1 (https=) |
| BR (1) | BR112019017103A2 (https=) |
| CA (1) | CA3051173A1 (https=) |
| DK (1) | DK3592393T3 (https=) |
| SI (1) | SI3592393T1 (https=) |
| WO (1) | WO2018163131A1 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190125310A (ko) | 2017-03-10 | 2019-11-06 | 퀴아펙 파마슈티칼스 에이비 | 방출가능한 접합체 |
| KR20220127380A (ko) | 2018-03-09 | 2022-09-19 | 퀴아펙 파마슈티칼스 에이비 | 방출가능한 항체 접합체 |
| CA3112473A1 (en) | 2018-09-12 | 2020-03-19 | Quiapeg Pharmaceuticals Ab | Releasable glp-1 conjugates |
| CN111175387B (zh) * | 2018-11-13 | 2022-06-07 | 成都康弘药业集团股份有限公司 | 一种米那普仑异构体的检测方法 |
| US10768173B1 (en) | 2019-09-06 | 2020-09-08 | Element Biosciences, Inc. | Multivalent binding composition for nucleic acid analysis |
| CN112168820B (zh) * | 2019-07-05 | 2023-09-29 | 中国科学院生物物理研究所 | SRCAP ATPase抑制剂在结直肠癌治疗中的应用 |
| US11287422B2 (en) | 2019-09-23 | 2022-03-29 | Element Biosciences, Inc. | Multivalent binding composition for nucleic acid analysis |
| KR102398574B1 (ko) | 2019-10-10 | 2022-05-13 | 주식회사 엘지에너지솔루션 | 전지 모듈 및 이를 포함하는 전지 팩 |
| CN110946844A (zh) * | 2019-12-11 | 2020-04-03 | 正大制药（青岛）有限公司 | 一种含有艾地骨化醇的复方控释制剂 |
| JP2023513895A (ja) * | 2020-02-03 | 2023-04-04 | スノーレトックス リミテッド | 組成物及び方法 |
| CN113456824B (zh) * | 2020-03-31 | 2023-03-31 | 四川大学华西医院 | 一种抗肿瘤载药纳米复合材料 |
| WO2022029178A1 (en) | 2020-08-05 | 2022-02-10 | Ascendis Pharma A/S | Conjugates comprising reversible linkers and uses thereof |
| CN112138170B (zh) * | 2020-09-28 | 2022-05-20 | 广东药科大学 | 一种预防顺铂药源性聋的缀合物及其制备方法和应用 |
| CN112316156B (zh) * | 2020-10-27 | 2022-03-15 | 四川大学 | 具抗氧化和抗菌性的胶原蛋白修复膜、其制备方法及应用 |
| CN112402620A (zh) * | 2020-12-07 | 2021-02-26 | 南开大学 | 肿瘤微环境还原响应性的纳米药物及其制备方法 |
| CN112457383B (zh) * | 2020-12-16 | 2022-06-17 | 阿南达 | 一种多肽、制备方法及其医药用途 |
| CN112516285B (zh) * | 2020-12-18 | 2022-09-02 | 中南大学 | 一种预防或治疗缺血/再灌注损伤的药物组合物及应用 |
| CN112574272B (zh) * | 2020-12-25 | 2021-09-21 | 中国医学科学院药用植物研究所 | 一种灵芝酸a衍生物的制备及其应用 |
| WO2022166720A1 (zh) * | 2021-02-05 | 2022-08-11 | 华南理工大学 | 基于血清白蛋白的融合蛋白、纳米组装体及其制备方法和应用 |
| CN112999196B (zh) * | 2021-03-03 | 2023-04-28 | 西安医学院 | 用于长效稳定释放的吗替麦考酚酯纳米制剂及其制备方法 |
| CN113133989B (zh) * | 2021-03-09 | 2023-04-25 | 西安医学院 | 一种用于抗结核药物利福平的长效制剂及制备方法 |
| CN114617876B (zh) * | 2022-01-28 | 2023-04-07 | 四川大学华西医院 | 一种抗肿瘤联合用药物 |
| CN114886817B (zh) * | 2022-06-02 | 2023-06-27 | 杭州配方师科技有限公司 | 一种弗来歇氏柳叶菜和酵母菌锌发酵复合物、制备方法及应用 |
| WO2023244517A1 (en) * | 2022-06-16 | 2023-12-21 | Merck Sharp & Dohme Llc | Interleukin-2 prodrugs |
| EP4573213A1 (en) | 2022-08-15 | 2025-06-25 | Element Biosciences, Inc. | Spatially resolved surface capture of nucleic acids |
| CN116333047A (zh) * | 2022-12-22 | 2023-06-27 | 四川大学华西医院 | 一种抗菌肽及其制备方法 |
| CN119331240B (zh) * | 2023-07-19 | 2026-01-02 | 南京大学 | 一种苯并环辛炔-聚乙二醇修饰的常山酮及其制备方法和应用 |
| KR102623104B1 (ko) * | 2023-08-23 | 2024-01-11 | 에프아이씨씨주식회사 | 보툴리눔톡신 결합체와 줄기세포 엑소좀 복합체를 유효성분으로 함유하는 피부 재생 및 주름 개선용 화장료 조성물 및 그의 제조 방법 |
| WO2025257419A1 (en) * | 2024-06-13 | 2025-12-18 | 4Moving Biotech | Glp-1 receptor agonist compounds for treating a proliferative synovial disorder |
| CN118415977B (zh) * | 2024-07-03 | 2024-08-23 | 山东新时代药业有限公司 | 一种米力农注射剂及其用途 |
| CN119709677B (zh) * | 2024-10-28 | 2025-05-06 | 皖西学院 | 一种糖基转移酶及其在制备金线莲苷中的应用 |
| CN119613558B (zh) * | 2024-12-12 | 2025-08-15 | 东北农业大学 | 一种抗磺胺嘧啶纳米抗体及其应用 |
| CN120531651B (zh) * | 2025-07-29 | 2025-09-30 | 清枫链食苏打饮品(吉林)有限公司 | 人参提取物、制备方法及其在美白嫩肤祛皱产品中的应用 |
Family Cites Families (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US200130A (en) * | 1878-02-12 | Improvement in joining sheet metal to wire-cloth for the construction of fly-traps | ||
| US4647447A (en) | 1981-07-24 | 1987-03-03 | Schering Aktiengesellschaft | Diagnostic media |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| US5304121A (en) | 1990-12-28 | 1994-04-19 | Boston Scientific Corporation | Drug delivery system making use of a hydrogel polymer coating |
| EP0563475B1 (en) | 1992-03-25 | 2000-05-31 | Immunogen Inc | Cell binding agent conjugates of derivatives of CC-1065 |
| US5395619A (en) | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
| US5886026A (en) | 1993-07-19 | 1999-03-23 | Angiotech Pharmaceuticals Inc. | Anti-angiogenic compositions and methods of use |
| US5637684A (en) | 1994-02-23 | 1997-06-10 | Isis Pharmaceuticals, Inc. | Phosphoramidate and phosphorothioamidate oligomeric compounds |
| ES2285707T3 (es) | 1994-10-21 | 2007-11-16 | Nps Pharmaceuticals, Inc. | Compuestos activos frente al receptor de calcio. |
| US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
| US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
| US5817856A (en) | 1995-12-11 | 1998-10-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Radiation-protective phospholipid and method |
| US5830600A (en) * | 1996-05-24 | 1998-11-03 | Sri International | Nonflammable/self-extinguishing electrolytes for batteries |
| JPH10175987A (ja) | 1996-12-13 | 1998-06-30 | Nof Corp | 重合性基含有有機リン酸エステル化合物およびその製造方法 |
| US6180095B1 (en) | 1997-12-17 | 2001-01-30 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| US5922897A (en) | 1998-05-29 | 1999-07-13 | Xerox Corporation | Surfactant processes |
| JP2000212191A (ja) * | 1999-01-26 | 2000-08-02 | Sankyo Co Ltd | リン酸誘導体 |
| US20030165849A1 (en) | 2000-11-28 | 2003-09-04 | Biliang Zhang | Methods and reagents for introducing a sulfhydryl group into the 5'-terminus of RNA |
| US6320041B1 (en) | 2001-04-13 | 2001-11-20 | Trilink Biotechnologies, Inc. | Pre-activated carbonyl linkers for the modification of oligonucleotides |
| US6743905B2 (en) | 2001-04-16 | 2004-06-01 | Applera Corporation | Mobility-modified nucleobase polymers and methods of using same |
| JP2005503425A (ja) | 2001-05-24 | 2005-02-03 | アレックザ モレキュラー デリヴァリー コーポレイション | 所定の吸入ルートによる薬剤エステルの送出 |
| US20100240730A1 (en) | 2002-02-20 | 2010-09-23 | Merck Sharp And Dohme Corp. | RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| US20040062748A1 (en) | 2002-09-30 | 2004-04-01 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| AU2004212941B2 (en) | 2003-02-14 | 2011-05-26 | Quanta Biodesign, Ltd | The selective and specific preparation of discrete PEG compounds |
| EP2478912B1 (en) | 2003-11-06 | 2016-08-31 | Seattle Genetics, Inc. | Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy |
| WO2005077966A1 (en) | 2004-02-10 | 2005-08-25 | Isis Pharmaceuticals, Inc. | Substituted pixyl protecting groups for oligonucleotide synthesis |
| CA2940803A1 (en) * | 2004-03-23 | 2005-10-27 | Ascendis Pharma Gmbh | Prodrug linker |
| EP1758575A1 (en) | 2004-06-11 | 2007-03-07 | Novo Nordisk A/S | Counteracting drug-induced obesity using glp-1 agonists |
| US20060063147A1 (en) | 2004-09-21 | 2006-03-23 | Chernov Boris K | Omega-amino-PEG-phosphoramidites and conjugates thereof |
| TW200612993A (en) | 2004-10-08 | 2006-05-01 | Alza Corp | Lipopolymer conjugates |
| AU2006304856A1 (en) | 2005-10-21 | 2007-04-26 | Synageva Biopharma Corp. | Glycolated and glycosylated poultry derived therapeutic proteins |
| WO2007055789A2 (en) | 2005-10-31 | 2007-05-18 | Neose Technologies, Inc. | Expression of soluble therapeutic proteins |
| AU2006316903B8 (en) | 2005-11-23 | 2010-10-14 | F. Hoffmann-La Roche Ag | Polynucleotide labelling reagent |
| EP2364735A3 (en) | 2005-12-16 | 2012-04-11 | Nektar Therapeutics | Branched PEG conjugates of GLP-1 |
| JP5140824B2 (ja) * | 2006-04-19 | 2013-02-13 | 国立大学法人 東京大学 | リゾホスファチジルスレオニンおよびその誘導体 |
| US7985783B2 (en) | 2006-09-21 | 2011-07-26 | The Regents Of The University Of California | Aldehyde tags, uses thereof in site-specific protein modification |
| WO2008067127A2 (en) | 2006-11-09 | 2008-06-05 | Alcon Research, Ltd. | Water insoluble polymer matrix for drug delivery |
| US20130195888A1 (en) | 2007-11-30 | 2013-08-01 | Abbvie | Ultrafiltration and diafiltration formulation methods for protein processing |
| US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
| AU2009209565B2 (en) | 2008-02-01 | 2013-09-19 | Ascendis Pharma As | Prodrug comprising a self-cleavable linker |
| TWI451876B (zh) | 2008-06-13 | 2014-09-11 | Lilly Co Eli | 聚乙二醇化之離脯胰島素化合物 |
| US8883211B2 (en) | 2008-07-10 | 2014-11-11 | Serina Therapeutics, Inc. | Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds |
| EP2334335A1 (en) | 2008-09-19 | 2011-06-22 | Nektar Therapeutics | Polymer conjugates of cd-np peptides |
| PT2432489T (pt) | 2009-05-20 | 2016-12-07 | Biomarin Pharm Inc | Variantes do péptido natriurético de tipo c |
| WO2011012722A1 (en) | 2009-07-31 | 2011-02-03 | Ascendis Pharma As | Prodrugs containing an aromatic amine connected by an amido bond to a linker |
| US9062094B2 (en) | 2010-01-22 | 2015-06-23 | Ascendis Pharma As | Dipeptide-based prodrug linkers for aliphatic amine-containing drugs |
| ES2584381T3 (es) | 2010-05-05 | 2016-09-27 | Prolynx Llc | Liberación controlada de compuestos activos desde conjugados macromoleculares |
| EP2600897A2 (en) | 2010-08-06 | 2013-06-12 | The Regents of the University of Colorado, A Body Corporate | Methods and compositions for the inhibition of fructokinase |
| CA3065178C (en) | 2010-12-13 | 2022-02-01 | Quiapeg Pharmaceuticals Ab | Functionalized polymers |
| CN103796657B (zh) * | 2011-07-19 | 2017-07-11 | 波涛生命科学有限公司 | 合成官能化核酸的方法 |
| CA2843506C (en) | 2011-08-12 | 2020-05-12 | Ascendis Pharma A/S | Carrier-linked prodrugs having reversible carboxylic ester linkages |
| AU2013276219B2 (en) | 2012-06-12 | 2018-03-08 | Quiapeg Pharmaceuticals Ab | Conjugates of biologically active molecules to functionalized polymers |
| WO2014061277A1 (ja) | 2012-10-19 | 2014-04-24 | 第一三共株式会社 | 親水性構造を含むリンカーで結合させた抗体－薬物コンジュゲート |
| KR102442906B1 (ko) * | 2013-12-19 | 2022-09-14 | 씨젠 인크. | 표적화된-약물 컨쥬게이트와 함께 사용되는 메틸렌 카바메이트 링커 |
| AU2015277100A1 (en) | 2014-06-20 | 2017-02-02 | Abgenomics International Inc. | HER2 antibody-drug conjugates |
| JP6369721B2 (ja) * | 2014-07-04 | 2018-08-08 | 国立大学法人 東京大学 | リゾホスファチジルセリン誘導体 |
| CN104725628B (zh) * | 2014-10-01 | 2018-04-17 | 厦门赛诺邦格生物科技股份有限公司 | 一种含可降解基团的单一官能化支化聚乙二醇、制备方法及其生物相关物质 |
| EP3242689A1 (en) | 2015-01-09 | 2017-11-15 | Ascendis Pharma Growth Disorders A/S | Cnp prodrugs |
| CA2979895A1 (en) | 2015-03-18 | 2016-09-22 | Immunobiochem Corporation | Conjugates for the treatment of cancer targeted at intracellular tumor-associated antigens |
| CN107921030B (zh) | 2015-08-14 | 2024-07-02 | 荣昌生物制药(烟台)股份有限公司 | 抗体-药物偶联物的共价连接子及其制备方法与应用 |
| CA3007976C (en) | 2016-01-08 | 2023-09-26 | Ascendis Pharma Growth Disorders A/S | Cnp prodrugs with large carrier moieties |
| DK3400019T3 (da) | 2016-01-08 | 2022-10-24 | Ascendis Pharma Growth Disorders As | CNP-prodrugs med bærerbinding ved ringenheden |
| GB201607827D0 (en) | 2016-05-04 | 2016-06-15 | Bicycle Therapeutics Ltd | Bicyclic peptide-toxin conjugates specific for MT1-MMP |
| US10624968B2 (en) | 2017-01-06 | 2020-04-21 | Bicyclerd Limited | Compounds for treating cancer |
| KR20190125310A (ko) * | 2017-03-10 | 2019-11-06 | 퀴아펙 파마슈티칼스 에이비 | 방출가능한 접합체 |
| KR20220127380A (ko) * | 2018-03-09 | 2022-09-19 | 퀴아펙 파마슈티칼스 에이비 | 방출가능한 항체 접합체 |
| CA3112473A1 (en) * | 2018-09-12 | 2020-03-19 | Quiapeg Pharmaceuticals Ab | Releasable glp-1 conjugates |
-
2018
- 2018-03-10 KR KR1020197024541A patent/KR20190125310A/ko not_active Ceased
- 2018-03-10 JP JP2019545923A patent/JP7152408B2/ja active Active
- 2018-03-10 BR BR112019017103-7A patent/BR112019017103A2/pt not_active Application Discontinuation
- 2018-03-10 AU AU2018231832A patent/AU2018231832A1/en not_active Abandoned
- 2018-03-10 EP EP18713014.1A patent/EP3592393B1/en active Active
- 2018-03-10 WO PCT/IB2018/051579 patent/WO2018163131A1/en not_active Ceased
- 2018-03-10 SI SI201830575T patent/SI3592393T1/sl unknown
- 2018-03-10 EP EP21208889.2A patent/EP4011396A1/en active Pending
- 2018-03-10 DK DK18713014.1T patent/DK3592393T3/da active
- 2018-03-10 CA CA3051173A patent/CA3051173A1/en active Pending
- 2018-03-10 CN CN201880014422.0A patent/CN110545850A/zh active Pending
- 2018-03-12 US US15/918,944 patent/US11786599B2/en active Active
-
2022
- 2022-09-29 JP JP2022155899A patent/JP7381684B2/ja active Active
-
2023
- 2023-08-15 US US18/234,142 patent/US20230381323A1/en active Pending
-
2024
- 2024-02-26 AU AU2024201279A patent/AU2024201279A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020512302A5 (https=) | ||
| US11629125B2 (en) | Elimination of hepatitis b virus with antiviral agents | |
| JP2015504650A5 (https=) | ||
| Roethle et al. | Identification and optimization of pteridinone Toll-like receptor 7 (TLR7) agonists for the oral treatment of viral hepatitis | |
| JP6860585B2 (ja) | 非環状抗ウイルス 優先出願の参照による組み込み | |
| JP2020524719A5 (https=) | ||
| JP7710215B2 (ja) | ピロール化合物 | |
| JP2007534636A5 (https=) | ||
| JP2020521740A5 (https=) | ||
| JP2006524669A5 (https=) | ||
| WO2018043747A1 (ja) | 抗ｂ型肝炎ウイルス剤 | |
| JP2017518959A5 (https=) | ||
| JP7648528B2 (ja) | モノマーおよびマルチマー抗ｈｂｖ薬 | |
| JP2016533761A5 (https=) | ||
| RU2016122908A (ru) | Соединения дигидропиримидина и их применение в фармацевтических препаратах | |
| IL201239A (en) | (s)-2-{[(2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydrofuran-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid isopropyl ester or a stereoisomer thereof, (s)-isopropyl 2-(((s)-((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate, a method of synthesizing the nucleotides and uses thereof | |
| JP2007505138A5 (https=) | ||
| JP2005526857A5 (https=) | ||
| JP2004502761A5 (https=) | ||
| WO2014182643A2 (en) | Methods for treating hcv infection | |
| JP2012519691A5 (https=) | ||
| JP2021535920A5 (https=) | ||
| JP2006509842A5 (https=) | ||
| JP2010540666A5 (https=) | ||
| JP2001335593A5 (https=) |